Research News

This summer, 19 University of Wisconsin-Madison Department of Medicine faculty members from seven divisions mentored 25 UW School of Medicine and Public Health (SMPH) students in the Shapiro Summer Research Program . In the program, students collaborate with faculty mentors for an eight- to 10-week, hypothesis-driven project. Topics span a...
Two recently published papers from the laboratory of Dudley Lamming, PhD (pictured above with graduate student Deyang Yu), assistant professor, Endocrinology, Diabetes and Metabolism, broke new ground in understanding the biology of a key protein that regulates metabolism and aging, and in identifying a drug that may be able to...
Photo (above): Attendees of the 2019 Department of Medicine Leadership Retreat pause briefly for a group photo. Back row, L to R: Vincent Cryns, MD; Nizar Jarjour, MD; Bennett Vogelman, MD; Michael Lucey, MD; Jeremy Smith, MD; Mariah Quinn, MD, MPH; Ann Sheehy, MD, MS; Nasia Safdar, MD, PhD; Sharon...
The Blue Ridge Institute for Medical Research (BRIMR), which is a clearinghouse of information about research funding to medical institutions from the National Institutes of Health (NIH), released their 2018 rankings of medical schools and departments. The University of Wisconsin Department of Medicine has climbed to 15th in the nation...
Ruth O'Regan, MD , Department of Medicine professor and chief of the department's Division of Hematology, Medical Oncology and Palliative Care, has been named Chief Scientific Officer (CSO) of the Big Ten Cancer Research Consortium (Big Ten CRC). The organization unites cancer centers at all Big Ten universities to facilitate...
A multi-institutional clinical study facilitated by the Big Ten Cancer Research Consortium is aimed at evaluating a combination of radiation and immunotherapy for treating advanced bladder cancer. Hamid Emamekhoo, MD , assistant professor (CHS), Hematology, Medical Oncology and Palliative Care, explained why the consortium aids recruitment. Only a subset of...
William Busse, MD , professor, Allergy, Pulmonary and Critical Care Medicine, commented in an article published by MD Magazine on a phase 3 clinical trial that he is leading. The BORA trial is investigating the long-term efficacy of benralizumab for treatment of asthma. Results indicate that the medication was remained...
Image (above): A scanning electron micrograph shows Candida albicans yeast (elongated structure at left) building an antifungal drug-resistant biofilm structure by secreting small, spherical extracellular vesicles (arrows) that deliver payloads of biofilm polymers to the extracellular matrix. The pathogenic yeast Candida albicans has a clinically frustrating habit: when it colonizes...
The Wisconsin Registry for Alzheimer’s Prevention (WRAP) has been awarded a five-year, $19 million renewal grant from the National Institutes of Health (NIH) to enable in-depth study of molecular hallmarks of the disease in the brain and spinal fluid. The additional funding will expand capacity for in-depth tests for biomarkers...
Rheumatoid arthritis is a painful and debilitating disease in which the body's immune system becomes dysfunctional, inappropriately attacking joint tissue and causing inflammation. A new research study is focusing on several as-yet-unsolved mysteries in the immunology of rheumatoid arthritis. Miriam Shelef, MD, PhD (pictured above), assistant professor, Rheumatology, has been...